Physician profile
Eric Rodriguez
NPI 1952664641
$7,448.90
in general payments reported to CMS, 2019-2025
49 companies · $1,901 in 2025
The $1,901 reported for 2025 was more than what 95% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,044 · 2022: $1,359 · 2023: $1,366 · 2024: $1,779 · 2025: $1,901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,046.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,139.46 | 2021-2025 | Trelegy Ellipta, Bexsero, Arexvy |
| Abbvie INC. | $708.80 | 2021-2025 | |
| Novo Nordisk INC | $658.50 | 2021-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $395.52 | 2021-2025 | |
| Amgen INC. | $347.02 | 2021-2025 | Evenity, Otezla, Repatha |
| Lilly USA, LLC | $322.58 | 2023-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $303.22 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Abbott Laboratories | $294.75 | 2021-2025 | Workmate Claris, Amplatzer, Viewmate |
| Shield Therapeutics INC | $283.42 | 2023-2025 | Accrufer |
| Exact Sciences Corporation | $220.00 | 2023-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $219.03 | 2022-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $210.48 | 2022-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $198.60 | 2021-2025 | Xifaxan, Trulance |
| Astellas Pharma US INC | $183.17 | 2021-2024 | Myrbetriq, Veozah |
| Janssen Pharmaceuticals, INC | $175.15 | 2022-2024 | Spravato, Invega |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.